Am Pharma

Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 15mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 15mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 15mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 15mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

• To improve glycemic control in adults with Type 2 diabetes mellitus
• Management of Obesity

Mounjaro 12.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 12.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 12.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 12.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

• To improve glycemic control in adults with Type 2 diabetes mellitus
• Management of Obesity

• This product may make a clicking sound as you prepare the dose. Do not prepare the dose by counting the clicks. Doing so could lead to using the wrong dose.
• Remove all pen needle covers before injecting a dose (there may be 2). If you are not sure what type of pen needle you have or how to use it, talk with the doctor.
• Do not share pen or cartridge devices with another person even if the needle has been changed. Sharing these devices may pass infections from one person to another. This includes infections you may not know you have.

Mounjaro 2.5mg Solution for Injection is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes and support weight management in individuals who are overweight and those with obesity. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite.

Mounjaro 2.5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the medication properly in the refrigerator.

Common side effects of Mounjaro 2.5mg Solution for Injection include nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are typically mild and improve over time. If they become severe or persistent, consult a doctor. They can help by adjusting the dose or suggesting ways to prevent them. Drinking plenty of water and staying hydrated may also help reduce discomfort from gastrointestinal symptoms.

Mounjaro 2.5mg Solution for Injection should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to become pregnant should avoid this medicine as it may cause harmful effects on the developing baby. Before taking this medicine, inform your doctor about all the other medicines you are taking to avoid interaction.

Anfoe 6000IU Injection is given by injection either under the skin or into a vein which will be decided by your doctor. Usually, the injections are given by a nurse or doctor. The dose depends on your body weight and the cause of your anemia. Iron supplements both before and during treatment may make this treatment more effective. Anfoe 6000IU Injection needs to be stored in a fridge but used at room temperature.

Medivorin Injection (50 mg/5 ml) typically contains Methotrexate, a chemotherapy agent and immune system suppressant. It is widely used for various conditions, depending on the specific formulation. Common uses include:

• Leukemia: Used as part of chemotherapy protocols for acute lymphoblastic leukemia (ALL).
• Breast Cancer, Lung Cancer, Head & Neck Cancer: Helps slow or stop the growth of cancer cells.
• Choriocarcinoma: Effective in the treatment of gestational trophoblastic neoplasia.

• Rheumatoid Arthritis: Methotrexate is a first-line disease-modifying anti-rheumatic drug (DMARD) for moderate to severe cases.
• Psoriasis: Helps control severe psoriasis by reducing inflammation and overproduction of skin cells.
• Crohn’s Disease: Sometimes used off-label for inflammatory bowel disease.

• Methotrexate is used to terminate ectopic pregnancies (non-viable pregnancies outside the uterus) in early stages by stopping cell growth.

Methotrexate works by inhibiting dihydrofolate reductase, an enzyme involved in DNA synthesis and cell replication. This action targets rapidly dividing cells (like cancer cells and cells involved in inflammation).

• Dosage: Must be carefully controlled by a healthcare professional due to its toxicity.
• Monitoring: Requires regular monitoring of liver function, kidney function, and blood cell counts.
• Side Effects: Can include nausea, fatigue, mouth sores, liver toxicity, and bone marrow suppression.

If you're considering or prescribed Medivorin Injection, please consult a healthcare provider for specific guidance tailored to your condition.

• Cancers of the lymphatic system known as non-Hodgkins lymphomas
• The inflammatory disease of the joints known as rheumatoid arthritis

Carboplatin 450mg injection is a chemotherapy drug used in the treatment of various types of cancer. It belongs to a class of medications known as platinum-based chemotherapy agents. The primary uses of carboplatin include:

1. Ovarian Cancer: Carboplatin is commonly used in the treatment of advanced ovarian cancer, often in combination with other chemotherapy drugs, to help shrink or slow the growth of tumors.

2. Non-Small Cell Lung Cancer (NSCLC): It is used to treat non-small cell lung cancer, usually in combination with other chemotherapy agents.

3. Small Cell Lung Cancer (SCLC): Carboplatin is also used to treat small cell lung cancer, either as a single agent or in combination with other chemotherapy drugs.

4. Testicular Cancer: Carboplatin is part of the treatment regimen for testicular cancer, particularly in patients who cannot tolerate other platinum-based chemotherapy agents like cisplatin.

5. Head and Neck Cancer: It is used as part of the treatment for head and neck cancers, often in combination with other chemotherapy or radiation therapy.

6. Bladder Cancer: Carboplatin may be used in treating advanced or metastatic bladder cancer, often in combination with other chemotherapy drugs.

7. Other Cancers: Carboplatin may also be used in the treatment of certain other cancers, such as endometrial cancer, soft tissue sarcomas, or lymphomas, depending on the specific case.

Carboplatin works by interfering with the DNA inside cancer cells, preventing them from dividing and multiplying, which helps to slow or stop the growth of cancer. It is usually administered via an intravenous infusion, typically in a hospital or clinic setting.

Common side effects of carboplatin include nausea, vomiting, low blood cell counts (which can increase the risk of infection, anemia, and bleeding), kidney issues, and nerve damage. The use of carboplatin is carefully monitored by healthcare professionals to manage these potential side effects.

Interferon Alpha 2B (IFN-α2b) Injection is a type of biological therapy that contains a synthetic version of a naturally occurring protein called interferon. Interferons are part of the body’s immune system and play a role in fighting viral infections and cancer. Interferon Alpha 2B is used for a variety of medical conditions, particularly in the treatment of certain types of cancers and viral infections.

1. Hepatitis C (Chronic)

   • Interferon Alpha 2B is used to treat chronic hepatitis C, often in combination with other medications, such as ribavirin. It works by boosting the immune system to fight the hepatitis C virus (HCV) and helps to reduce liver damage caused by the infection.
   • Though newer direct-acting antiviral (DAA) drugs are now the primary treatment for hepatitis C, interferon alpha 2b may still be used in some cases where these newer treatments are not available or appropriate.

2. Hepatitis B (Chronic)

   • It is also used to treat chronic hepatitis B (HBV), a viral infection that affects the liver. Interferon Alpha 2B helps the immune system clear the virus and can reduce the risk of complications such as liver cirrhosis and liver cancer.

3. Cancer Treatment

   • Melanoma: Interferon Alpha 2B is used as an adjuvant therapy (following surgery) for stage III melanoma to reduce the risk of recurrence and improve survival outcomes.
   • Hairy Cell Leukemia: It is used to treat hairy cell leukemia, a rare type of cancer that affects the blood and bone marrow. Interferon Alpha 2B can help reduce the number of cancerous cells and improve blood cell counts.
   • Kaposi’s Sarcoma: This is a cancer often associated with HIV/AIDS. Interferon Alpha 2B can be used to treat Kaposi's sarcoma, helping to slow the growth of the cancerous cells.
   • Chronic Myelogenous Leukemia (CML): In some cases, interferon Alpha 2B is used to manage CML, a type of leukemia that affects white blood cells.

4. Genital Warts (Human Papillomavirus - HPV)

   • Interferon Alpha 2B is sometimes used in the treatment of genital warts caused by HPV. It works by enhancing the immune system’s ability to fight the viral infection and may help reduce the size of warts.

5. Other Viral Infections

   • Interferon Alpha 2B can be used to treat other viral infections, including condylomata acuminata (genital warts), chronic viral infections, and certain viral strains that may be resistant to other treatments.

• Interferon Alpha 2B works by boosting the body's immune response. It binds to specific receptors on cells, stimulating the immune system to fight against infections and abnormal cells (such as cancer cells).
• In viral infections, it inhibits viral replication and enhances the immune system’s ability to destroy infected cells.
• In cancer, it helps by increasing the activity of immune cells that target and kill cancerous cells.

• Interferon Alpha 2B is usually administered as an injectable solution. It can be given either subcutaneously (under the skin) or intramuscularly (into the muscle), depending on the specific condition and the patient's treatment plan.
• The frequency and dose of administration vary based on the condition being treated. It may be given daily, weekly, or as a few doses per week.

Erythropoietin (2000 IU injection) is a synthetic form of a naturally occurring hormone that stimulates the production of red blood cells in the bone marrow. It is used primarily in the treatment of anemia associated with various medical conditions. Here are the main uses of Erythropoietin injections:

• Erythropoietin is often prescribed to treat anemia in patients with chronic kidney disease (CKD). In CKD, the kidneys are unable to produce enough erythropoietin, which is necessary for stimulating red blood cell production. By administering synthetic erythropoietin, the injection helps increase red blood cell count and alleviate symptoms of anemia, such as fatigue and weakness.

• Erythropoietin is used to treat anemia in cancer patients undergoing chemotherapy. Chemotherapy can suppress the bone marrow, reducing the production of red blood cells. Erythropoietin injections stimulate red blood cell production, helping manage the anemia caused by the treatment.
• It is particularly helpful in patients with non-myeloid cancers (like breast, lung, and colon cancer) who develop chemotherapy-induced anemia.

• In patients with HIV who are receiving antiretroviral therapy (ART), erythropoietin injections may be used to manage anemia. Some HIV treatments can reduce red blood cell production, leading to anemia, and erythropoietin can help address this issue.

• Erythropoietin injections are sometimes used in patients who have undergone major surgery, particularly in cases where blood loss during the procedure leads to anemia. The injection helps increase red blood cell production to compensate for the loss.

• Erythropoietin is sometimes used to treat anemia in premature infants, as they may have low levels of erythropoietin and reduced red blood cell production due to their underdeveloped kidneys.

Erythropoietin is a hormone naturally produced by the kidneys in response to low oxygen levels in the blood. It stimulates the bone marrow to produce more red blood cells. The synthetic form of erythropoietin (used in injections) mimics this effect, promoting the production of red blood cells to help alleviate anemia.

• Erythropoietin is usually administered as an injection either subcutaneously (under the skin) or intravenously (into the vein), depending on the condition being treated and the patient's needs.
• The dose and frequency depend on the individual’s hemoglobin levels and the underlying cause of anemia. A dose of 2000 IU is generally administered as a weekly or bi-weekly injection, though the specific regimen is determined by a healthcare provider.

• Side Effects: Common side effects may include injection site reactions, headache, fever, and joint pain. More serious side effects include high blood pressure (hypertension), blood clots, and seizures.
• Iron Levels: Patients receiving erythropoietin may require iron supplementation, as adequate iron is necessary for red blood cell production. Blood tests to monitor iron levels may be required.
• Overuse: Excessive erythropoietin use can lead to polycythemia, a condition where too many red blood cells are produced, potentially leading to blood clots, stroke, or heart problems.
• Monitoring: Regular monitoring of hemoglobin levels, blood pressure, and kidney function is essential during erythropoietin therapy.

Encoxel 60 Injection is an anticoagulant used to prevent and treat harmful blood clots. It stops the existing clots from getting any bigger and restricts the formation of any new clot. It is also helpful in the prevention of blood clots in veins, a condition called deep vein thrombosis, and pulmonary embolism.

Encoxel 60 Injection is injected under the skin by a doctor or nurse. It should not be injected into a muscle. The dose and length of treatment are based on your medical condition, your response to the medicine, and what you are being treated for. It may also be based on your age and weight. It is important to keep using this medicine even if you do not notice any symptoms because it is preventing future harm. If you stop taking it, you could get a blood clot. While taking this medicine you should avoid doing things that increase your risk of bleeding or injury.

Trasturel 440 mg Injection is an anti-cancer medicine used in the treatment of HER2-positive Breast cancer and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.

Trasturel 440 mg Injection contains Trastuzumab as an active ingredient, which belongs to the class of monoclonal antibodies. It works by inhibiting the abnormal growth of cancer cells and, finally, causes the initiation of programmed cell death.

Trasturel 440 mg Injection may cause certain side effects such as abdominal pain, chills, diarrhoea, fatigue, nausea, back pain, bone pain, edema, insomnia, fever, dizziness, headache, vomiting, cough, rash, and injection site reactions. If the side effects persist or bother you, please consult your doctor. Trasturel 440 mg Injection will be administered by a trained doctor. Hence, do not self-administer.

Avoid taking it and inform your doctor if you are allergic to Trasturel 440 mg Injection or its components. Inform your doctor if you have any cardiovascular conditions, lung problems, or liver/kidney disease, as it can cause adverse effects. Trasturel 440 mg Injection is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand.

Uses of Trasturel 440 mg Injection

Directions for Use

Medicinal Benefits

Trasturel 440 mg Injection contains Trastuzumab, which is used for treating patients with HER2-positive breast cancer and HER2-positive metastatic gastroesophageal adenocarcinoma. This medicine works by inhibiting the excess production of a human epidermal growth factor receptor 2 (HER2) protein in the mammalian cells. This causes inhibition of the cancer cell growth and, finally, initiation of programmed cell death.

How Trasturel 440 mg Injection Works

Storage

Leucovorin Calcium (brand names include Wellcovorin, Folinic acid) is a form of folinic acid, a derivative of folic acid, and is used in medical treatments to counteract the toxic effects of certain chemotherapy drugs, as well as in other medical conditions. The 50 mg Leucovorin Calcium Injection is primarily used for the following purposes:

• Leucovorin is commonly used as a "rescue" medication to prevent or treat the toxic effects of methotrexate. Methotrexate is a chemotherapy drug that can interfere with the body's ability to metabolize folic acid, leading to potential toxicity (e.g., bone marrow suppression, mucositis, and renal damage).
• Leucovorin helps "rescue" normal cells by providing them with the folate they need to function properly, which reduces the harmful effects of methotrexate on healthy tissues.

• Leucovorin is sometimes used to treat folate deficiency or to correct megaloblastic anemia caused by insufficient folate. It provides the body with an active form of folate that can be used in cellular processes such as DNA synthesis.
• It is used in patients who cannot absorb or utilize folic acid effectively, such as those with malabsorption syndromes or patients who have undergone certain types of gastrointestinal surgery.

• Leucovorin is used in combination with certain chemotherapy drugs (such as 5-fluorouracil (5-FU)) to enhance their effectiveness. In these cases, leucovorin acts as a chemoadjuvant, which means it helps to improve the efficacy of the chemotherapy drug by stabilizing its binding to its target enzyme, thus enhancing the anticancer effect.

• In some cases, leucovorin is used to reduce the toxicity of the drug pyrimethamine, which is used to treat malaria and certain parasitic infections. Pyrimethamine can inhibit the action of folic acid in the body, and leucovorin can be used to reverse or mitigate this effect.

• Leucovorin may be used for certain neurological conditions or conditions related to dihydrofolate reductase inhibition, though these uses are less common.

• Leucovorin is a form of folate that does not require conversion to the active form in the body, unlike folic acid. When administered, it can directly enter cells and participate in metabolic processes, such as DNA synthesis and repair, which is why it is used in the treatment of folate deficiency and as a rescue agent in chemotherapy.

Carboplatin injection is a chemotherapy medication used to treat various types of cancers. It belongs to a class of drugs known as platinum-based antineoplastic agents, which work by interfering with the DNA of cancer cells, preventing their growth and replication.

1. Ovarian Cancer:

   • Carboplatin is commonly used to treat advanced ovarian cancer, either alone or in combination with other chemotherapy drugs.

2. Lung Cancer:

   • It is used for the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) in combination with other drugs.

3. Head and Neck Cancer:

   • Carboplatin may be used in combination therapy to treat cancers of the head and neck region.

4. Testicular Cancer:

   • It is sometimes used for recurrent or refractory testicular cancer, usually in combination with other chemotherapeutic agents.

5. Bladder Cancer:

   • Carboplatin may be used to treat advanced bladder cancer when other treatments are not effective.

6. Breast Cancer (Off-Label Use):

   • It is occasionally used off-label for triple-negative breast cancer (TNBC), particularly in patients with BRCA mutations.

• Carboplatin forms cross-links with DNA strands in cancer cells, preventing DNA replication and transcription, leading to cell death.
• It is less reactive but more stable than cisplatin, with fewer side effects, especially regarding kidney toxicity.

• Nausea and vomiting
• Fatigue
• Low blood cell counts (anemia, neutropenia, thrombocytopenia)
• Loss of appetite
• Temporary hair loss
• Changes in kidney or liver function

1. Severe Bone Marrow Suppression:
   • This can lead to life-threatening infections or bleeding due to low white blood cells or platelets.
2. Kidney Toxicity:
   • Though less nephrotoxic than cisplatin, regular monitoring of kidney function is still necessary.
3. Hearing Loss (Ototoxicity):
   • Carboplatin can cause tinnitus or hearing impairment, particularly in higher doses.
4. Allergic Reactions:
   • Hypersensitivity reactions, including rash, itching, and difficulty breathing, can occur, especially after multiple doses.

Fulvestrant 250 mg/mL Injection is a medication primarily used in the treatment of hormone receptor-positive breast cancer, especially in postmenopausal women. Fulvestrant is an estrogen receptor antagonist that works by blocking the action of estrogen on estrogen receptors, preventing the growth of estrogen-dependent breast cancer cells.

1. Hormone Receptor-Positive Breast Cancer

   • Fulvestrant is used to treat metastatic hormone receptor-positive (HR-positive) breast cancer in postmenopausal women. It is typically prescribed when the cancer has become resistant to other treatments, such as aromatase inhibitors or tamoxifen.
   • It works by binding to the estrogen receptors on the cancer cells, causing them to degrade and leading to a reduction in the cancer cells' ability to grow and divide. This effectively starves the tumor of the estrogen it needs to grow.

2. Adjuvant Therapy (After Surgery)

   • Fulvestrant can also be used as adjuvant therapy (a treatment given after surgery) in certain cases of early-stage breast cancer that is estrogen receptor-positive to reduce the risk of recurrence.

3. Combination Therapy

   • Fulvestrant is sometimes used in combination with other targeted therapies or chemotherapies for patients with advanced breast cancer that has progressed despite prior treatments.

Fulvestrant is an estrogen receptor antagonist that blocks and downregulates the estrogen receptor. It binds to the estrogen receptor on cancer cells, leading to the destruction of these receptors. This prevents estrogen from stimulating the growth and proliferation of cancer cells that rely on estrogen to grow.

Unlike some other anti-estrogen treatments like tamoxifen, which only block estrogen receptors, fulvestrant also causes the receptor to be degraded, making it more effective in reducing the growth of hormone-dependent cancer cells.

• Injection site reactions (pain, redness, swelling)
• Hot flashes
• Fatigue
• Nausea and vomiting
• Joint pain or muscle pain
• Headaches
• Increased liver enzymes (monitoring may be required)
• Loss of appetite
• Weight gain

• Severe allergic reactions (rash, itching, swelling, trouble breathing)
• Liver toxicity (e.g., jaundice, abdominal pain)
• Bone pain or increased risk of fractures due to reduced bone density
• Blood clots or deep vein thrombosis (DVT)

• Liver Function: Fulvestrant can cause liver enzyme abnormalities, so liver function should be monitored during treatment, especially in patients with existing liver disease.
• Pregnancy and Breastfeeding: Fulvestrant is contraindicated in pregnancy and breastfeeding due to the potential for harm to the fetus or infant. It should only be used when the potential benefit justifies the potential risk to the fetus, and women of childbearing age should use effective contraception during treatment.
• Bone Health: Patients on fulvestrant are at risk for bone thinning (osteoporosis), especially with long-term use. Bone health should be monitored, and appropriate preventive measures like calcium and vitamin D supplementation may be recommended.

Fuvestrol (Fulvestrant) is an injectable drug that contains Fulvestrant, a selective estrogen receptor downregulator (SERD). It is primarily used for treating hormone receptor-positive breast cancer in women. Fulvestrant works by blocking and degrading estrogen receptors, which helps slow or stop the growth of breast cancer cells that depend on estrogen.

1. Hormone Receptor-Positive Breast Cancer (Postmenopausal Women)

   • Fuvestrol is indicated for the treatment of advanced or metastatic hormone receptor-positive (HR+) breast cancer in postmenopausal women who have disease progression after anti-estrogen therapy (e.g., tamoxifen).
   • It helps in cases where tumors are dependent on estrogen signaling for growth by downregulating estrogen receptors.

2. Combination Therapy for Advanced Breast Cancer

   • Used in combination with other targeted therapies, such as:
     • Palbociclib, Ribociclib, or Abemaciclib: Cyclin-dependent kinase (CDK) inhibitors, enhancing the efficacy of Fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer.
     • This combination is particularly effective after prior endocrine therapy failure.

Fulvestrant is a SERD that binds to estrogen receptors and blocks the effects of estrogen on cancer cells. Unlike selective estrogen receptor modulators (SERMs) such as tamoxifen, Fulvestrant leads to degradation of the estrogen receptor, making it a more potent anti-estrogen agent. This helps reduce tumor progression in estrogen-dependent breast cancer.

• Initial dose: 500 mg on days 1, 15, and 29.
• Maintenance dose: 500 mg once every 28 days thereafter.
• The injection is given as a slow intramuscular (IM) injection into the buttock muscles.

1. Injection Site Reactions

   • Pain, swelling, or bruising at the injection site.

2. Hot Flashes

   • A common side effect due to estrogen suppression.

3. Fatigue and Weakness

   • Often seen during long-term therapy.

4. Nausea

   • Mild nausea can occur but is usually manageable with dietary adjustments.

5. Bone Pain and Joint Pain

   • Associated with estrogen deprivation, especially in postmenopausal women.

6. Elevated Liver Enzymes

   • Regular liver function tests are advised during treatment.

• Thromboembolic Events (Blood Clots): Increased risk of deep vein thrombosis (DVT) or pulmonary embolism.
• Liver Damage: Severe liver dysfunction, although rare, can occur, requiring regular monitoring of liver enzymes.
• Allergic Reactions: Rare but serious hypersensitivity reactions can occur.

• Pregnancy and Breastfeeding: Fuvestrol should not be used during pregnancy or while breastfeeding, as it may harm the fetus or infant.
• Liver Impairment: Dose adjustments may be required in patients with moderate to severe liver impairment.
• Bleeding Disorders: Caution is advised in patients with bleeding disorders or those on anticoagulant therapy, as intramuscular injections may cause bleeding or hematomas.

Cisplatin is a platinum-based chemotherapy drug used to treat various types of cancers. It works by interfering with the DNA of cancer cells, preventing their replication and leading to cell death. Cisplatin is usually administered as part of a combination chemotherapy regimen.

1. Testicular Cancer

   • Cisplatin is a key component of first-line chemotherapy regimens for advanced testicular cancer, often in combination with other drugs such as bleomycin and etoposide.

2. Ovarian Cancer

   • Used to treat advanced ovarian cancer, particularly in patients who have relapsed after initial treatments.

3. Bladder Cancer

   • Effective in the treatment of advanced bladder cancer, especially when surgery or radiation is not viable.

4. Lung Cancer

   • Commonly used in the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) in combination with other chemotherapy agents.

5. Head and Neck Cancers

   • Often used to treat head and neck squamous cell carcinoma, either alone or in combination with radiation therapy.

6. Esophageal Cancer

   • Cisplatin is part of chemotherapy regimens for treating esophageal carcinoma in advanced or metastatic stages.

Cisplatin forms cross-links between and within DNA strands in cancer cells, preventing DNA replication and transcription. This leads to apoptosis (programmed cell death) of rapidly dividing cancer cells.

• The dosage varies depending on the type and stage of cancer, as well as the patient’s overall health.
• Typical dose: 50–100 mg/m² every 3–4 weeks, administered via slow intravenous infusion.
• Adequate hydration before and after Cisplatin administration is crucial to reduce nephrotoxicity (kidney damage).

1. Nausea and Vomiting

   • Severe nausea and vomiting are common but can be managed with antiemetic medications.

2. Nephrotoxicity (Kidney Damage)

   • Requires pre- and post-treatment hydration to minimize kidney damage. Regular kidney function tests are essential.

3. Ototoxicity (Hearing Loss)

   • Can cause tinnitus (ringing in the ears) or permanent hearing loss, especially at higher doses.

4. Peripheral Neuropathy

   • Numbness, tingling, or pain in the hands and feet due to nerve damage.

5. Bone Marrow Suppression

   • Leads to reduced levels of white blood cells, red blood cells, and platelets, increasing the risk of infections, anemia, and bleeding.